Cessation of nucleos(t)ide analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients

Van Hees, S; Bourgeois, S; Van Vlierberghe, H; Sersté, T; Francque, S; Michielsen, P; Sprengers, D; Reynaert, H; Henrion, J; Negrin Dastis, S; DELWAIDE, Jean; Lasser, L; Decaestecker, J; Orlent, H; Janssens, F; Robaeys, G; Colle, I; Starkel, P; Moreno, C; Nevens, F; Vanwolleghem, T

Paper published in a journal (Scientific congresses and symposiums)

Van Hees, S; Bourgeois, S; Van Vlierberghe, H et al.

2017 • In Hepatology, 66 (S1), p. 934

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/215632

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

poster AASLD 2017.pdf

Publisher postprint (89.41 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Van Hees, S

Bourgeois, S

Van Vlierberghe, H

Sersté, T

Francque, S

Michielsen, P

Sprengers, D

Reynaert, H

Henrion, J

Negrin Dastis, S

More authors (11 more)

Language :

English

Title :

Cessation of nucleos(t)ide analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients

Publication date :

October 2017

Event name :

Liver Meeting American Association for the Study of Liver Diseases

Event place :

Washington, United States

Event date :

du 20 octobre 2017 au 24 octobre 2017

Audience :

International

Journal title :

Hepatology

ISSN :

0270-9139

eISSN :

1527-3350

Publisher :

Wiley, Hoboken, United States - New Jersey

Volume :

Issue :

Pages :

A934

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 09 November 2017

Statistics

Number of views

51 (1 by ULiège)

Number of downloads

70 (0 by ULiège)

More statistics